tiprankstipranks
Trending News
More News >
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
US Market

Editas Medicine (EDIT) Income Statement

Compare
3,546 Followers

Editas Medicine Income Statement

Last quarter (Q3 2025), Editas Medicine's total revenue was $7.54M, an increase of 12265.57% from the same quarter last year. In Q3, Editas Medicine's net income was $-25.12M. See Editas Medicine’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 32.31M$ 78.12M$ 19.71M$ 25.54M$ 90.73M
Gross Profit
$ 32.31M$ 72.06M$ 13.38M$ 20.49M$ -67.26M
Operating Expenses
$ 283.47M$ 241.24M$ 239.32M$ 213.64M$ 67.58M
Depreciation and Amortization
$ 5.81M$ 6.06M$ 6.34M$ 5.05M$ 3.96M
EBITDA
$ -233.11M$ -163.12M$ -219.61M$ -188.09M$ -130.88M
Operating Income
$ -251.15M$ -169.18M$ -225.95M$ -193.15M$ -134.84M
Other Income/Expenses
$ 14.06M$ 15.96M$ 5.52M$ 644.00K$ 18.86M
Pretax Income
$ -237.09M$ -153.22M$ -220.43M$ -192.50M$ -115.98M
Net Income
$ -237.09M$ -153.22M$ -220.43M$ -192.50M$ -115.98M
Per Share Metrics
Basic EPS
$ -2.88$ -2.02$ -3.21$ -2.85$ -1.98
Diluted EPS
$ -2.88$ -2.02$ -3.21$ -2.85$ -1.98
Weighted Average Shares Outstanding
82.34M 75.97M 68.66M 67.62M 58.61M
Weighted Average Shares Outstanding (Diluted)
82.34M 75.97M 68.66M 67.62M 58.61M
Currency in USD

Editas Medicine Earnings and Revenue History